UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nogo receptor antagonist LOTUS exerts suppression on axonal growth‐inhibiting receptor PIR‐B

Journal of neurochemistry, 2020-11, Vol.155 (3), p.285-299

2020

Volltextzugriff (PDF)

Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS

Neuroscience, 2017-07, Vol.356, p.265-274

2017

Volltextzugriff (PDF)

LOTUS suppresses amyloid β-induced dendritic spine elimination through the blockade of amyloid β binding to PirB

Molecular medicine (Cambridge, Mass.), 2022-12, Vol.28 (1), p.154-154, Article 154

2022

Volltextzugriff (PDF)

The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans

Neuroscience letters, 2018-09, Vol.683, p.61-68

2018

Volltextzugriff (PDF)

LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice

PloS one, 2017-09, Vol.12 (9), p.e0184258-e0184258

2017

Volltextzugriff (PDF)

Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy

Experimental neurology, 2020-01, Vol.323, p.113068-113068, Article 113068

2020

Volltextzugriff (PDF)

PDZD8-deficient mice manifest behavioral abnormalities related to emotion, cognition, and adaptation due to dyslipidemia in the brain

Molecular brain, 2023-01, Vol.16 (1), p.11-18, Article 11

2023

Volltextzugriff (PDF)

Nogo Receptor Antagonist LOTUS Promotes Neurite Outgrowth through Its Interaction with Teneurin-4

Cells (Basel, Switzerland), 2024-08, Vol.13 (16), p.1369

2024

Volltextzugriff (PDF)

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real‐world clinical practice: Results of a 36‐month post‐marketing surveillance study (J‐STEP/LT)

Journal of diabetes investigation, 2021-02, Vol.12 (2), p.184-199

2021

Volltextzugriff (PDF)

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24‐month interim analysis of a long‐term post‐marketing study (J‐STEP/LT)

Journal of diabetes investigation, 2020-07, Vol.11 (4), p.906-916

2020

Volltextzugriff (PDF)

LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand

Molecular and cellular neuroscience, 2014-07, Vol.61, p.211-218

2014

Volltextzugriff (PDF)

Laparoscopic Repair Using Self-Fixating Mesh in an Adult Patient with a Sciatic Hernia and Irreducible Small Bowel: A Case Report and Literature Review

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2023-06, Vol.90 (3), p.301-305, Article JNMS.2023_90-403

2023

Volltextzugriff (PDF)

Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS

Scientific reports, 2017-09, Vol.7 (1), p.12119-9, Article 12119

2017

Volltextzugriff (PDF)

Long‐term safety and efficacy of the sodium–glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week open‐label, multicenter, post‐marketing clinical study

Journal of diabetes investigation, 2019-11, Vol.10 (6), p.1518-1526

2019

Volltextzugriff (PDF)

Safety and efficacy of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world clinical practice: Results of 3‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT)

Journal of diabetes investigation, 2019-09, Vol.10 (5), p.1272-1283

2019

Volltextzugriff (PDF)

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world practice: Results of 12‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT)

Journal of diabetes investigation, 2020-01, Vol.11 (1), p.132-141

2020

Volltextzugriff (PDF)

Cartilage Acidic Protein—1B (LOTUS), an Endogenous Nogo Receptor Antagonist for Axon Tract Formation

Science (American Association for the Advancement of Science), 2011-08, Vol.333 (6043), p.769-773

2011

Volltextzugriff (PDF)

Huge esophageal gastrointestinal stromal tumor successfully resected under mediastino-laparoscopic transhiatal esophagectomy: a case report

Surgical case reports, 2022-06, Vol.8 (1), p.109-109, Article 109

2022

Volltextzugriff (PDF)

Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A subanalysis of a post‐marketing study (J‐STEP/EL Study)

Journal of diabetes investigation, 2020-03, Vol.11 (2), p.405-416

2020

Volltextzugriff (PDF)

Changes in maxillary dental arch morphology after implant treatment in the alveolar cleft region

Clinical and experimental dental research, 2021-08, Vol.7 (4), p.484-489

2021

Volltextzugriff (PDF)

Axonal branching in lateral olfactory tract is promoted by Nogo signaling

Scientific reports, 2016-12, Vol.6 (1), p.39586-39586, Article 39586

2016

Volltextzugriff (PDF)

LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth

Neural regeneration research, 2015, Vol.10 (1), p.46-48

2015

Volltextzugriff (PDF)

Pharmacokinetics and brain penetration of carbapenems in mice

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-05, Vol.22 (5), p.346-349

2016

Volltextzugriff (PDF)

Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation

Journal of neuroinflammation, 2018-02, Vol.15 (1), p.46-46, Article 46

2018

Volltextzugriff (PDF)

Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post‐marketing study (J‐STEP/EL Study)

Journal of diabetes investigation, 2017-11, Vol.8 (6), p.766-775

2017

Volltextzugriff (PDF)

1 – 25 von 482

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(388)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(412)
Japanisch
(99)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Life Sciences & Biomedicine
(164)
Humans
(118)
Male
(74)
Female
(73)
Animals
(52)
Middle Aged
(48)
Aged
(45)
Adult
(40)
Physical Sciences
(40)
Biological And Medical Sciences
(35)
Chemistry
(31)
Technology
(30)
Pharmacology & Pharmacy
(28)
Medical Sciences
(27)
Mice
(25)
Science & Technology - Other Topics
(22)
Japan
(21)
Medicine
(21)
Surgery
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Nogo receptor antagonist LOTUS exerts suppression on axonal growth‐inhibiting receptor PIR‐B

Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS

LOTUS suppresses amyloid β-induced dendritic spine elimination through the blockade of amyloid β binding to PirB

The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans

LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice

Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy

PDZD8-deficient mice manifest behavioral abnormalities related to emotion, cognition, and adaptation due to dyslipidemia in the brain

Nogo Receptor Antagonist LOTUS Promotes Neurite Outgrowth through Its Interaction with Teneurin-4

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real‐world clinical practice: Results of a 36‐month post‐marketing surveillance study (J‐STEP/LT)

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24‐month interim analysis of a long‐term post‐marketing study (J‐STEP/LT)

LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand

Laparoscopic Repair Using Self-Fixating Mesh in an Adult Patient with a Sciatic Hernia and Irreducible Small Bowel: A Case Report and Literature Review

Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS

Long‐term safety and efficacy of the sodium–glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week open‐label, multicenter, post‐marketing clinical study

Safety and efficacy of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world clinical practice: Results of 3‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT)

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world practice: Results of 12‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT)

Cartilage Acidic Protein—1B (LOTUS), an Endogenous Nogo Receptor Antagonist for Axon Tract Formation

Huge esophageal gastrointestinal stromal tumor successfully resected under mediastino-laparoscopic transhiatal esophagectomy: a case report

Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A subanalysis of a post‐marketing study (J‐STEP/EL Study)

Changes in maxillary dental arch morphology after implant treatment in the alveolar cleft region

Axonal branching in lateral olfactory tract is promoted by Nogo signaling

LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth

Pharmacokinetics and brain penetration of carbapenems in mice

Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation

Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post‐marketing study (J‐STEP/EL Study)

Suchergebnisse filtern